You are here

Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use

Last updated on February 23, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Floro, , 6900 Norway
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Tobacco Use Cessation
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female daily smokeless tobacco users aged 18 years and older, who are
motivated to stop use of all tobacco products.

- Subjects must be daily users of nicotine containing smokeless tobacco and using
smokeless tobacco on at least 8 occasions per day averaged over a week.

- Have used smokeless tobacco for at least 1 year prior to screening with no period of
abstinence >3 months in the past year.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects using nicotine containing products (including smoking tobacco) other than
smokeless tobacco for 3 months prior to screening.

- Subjects with exhaled Carbon Monoxide (CO) >10 ppm at baseline.

- Subjects who have used varenicline, bupropion, or NRT within 3 months of screening.

- Subjects currently or within the past 12 months requiring treatment for depression or
have a current or prior history of panic disorder, psychosis, bipolar disorder or any
other serious mental illness.

NCT00717093
Pfizer
Completed
Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Tobacco Use Cessation
NCT00717093
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now